These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19459807)

  • 1. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.
    Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM
    Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
    Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G
    Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
    Alberti M; Valoti E; Piras R; Bresin E; Galbusera M; Tripodo C; Thaiss F; Remuzzi G; Noris M
    Am J Transplant; 2013 Aug; 13(8):2201-6. PubMed ID: 23731345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.
    Ranghino A; Tognarelli G; Basso E; Messina M; Manzione AM; Daidola G; Segoloni GP
    Transplant Proc; 2013 Sep; 45(7):2785-7. PubMed ID: 24034049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
    Chan MR; Thomas CP; Torrealba JR; Djamali A; Fernandez LA; Nishimura CJ; Smith RJ; Samaniego MD
    Am J Kidney Dis; 2009 Feb; 53(2):321-6. PubMed ID: 18805611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
    Le Quintrec M; Zuber J; Moulin B; Kamar N; Jablonski M; Lionet A; Chatelet V; Mousson C; Mourad G; Bridoux F; Cassuto E; Loirat C; Rondeau E; Delahousse M; Frémeaux-Bacchi V
    Am J Transplant; 2013 Mar; 13(3):663-75. PubMed ID: 23356914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M; Caprioli J; Bresin E; Mossali C; Pianetti G; Gamba S; Daina E; Fenili C; Castelletti F; Sorosina A; Piras R; Donadelli R; Maranta R; van der Meer I; Conway EM; Zipfel PF; Goodship TH; Remuzzi G
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.
    Le Quintrec M; Lionet A; Kamar N; Karras A; Barbier S; Buchler M; Fakhouri F; Provost F; Fridman WH; Thervet E; Legendre C; Zuber J; Frémeaux-Bacchi V
    Am J Transplant; 2008 Aug; 8(8):1694-701. PubMed ID: 18557729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
    Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.
    Caprioli J; Noris M; Brioschi S; Pianetti G; Castelletti F; Bettinaglio P; Mele C; Bresin E; Cassis L; Gamba S; Porrati F; Bucchioni S; Monteferrante G; Fang CJ; Liszewski MK; Kavanagh D; Atkinson JP; Remuzzi G;
    Blood; 2006 Aug; 108(4):1267-79. PubMed ID: 16621965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome.
    Davin JC; Buter N; Groothoff J; van Wijk J; Bouts A; Strain L; Goodship T
    Pediatr Nephrol; 2009 Sep; 24(9):1757-60. PubMed ID: 19373492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
    J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
    Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange.
    Reid VL; Mullan A; Erwig LP
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24005975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D; Rittich S; Malina M; Seeman T; Marinov I; Riedl M; Hrachovinova I
    Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.